The DSP Gene Skin Fragility-Woolly Hair Syndrome Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the DSP gene, which are linked to the development of Skin Fragility-Woolly Hair Syndrome (SF-WHS). This rare genetic condition is characterized by a combination of dermatological and hair abnormalities, including fragile skin that is prone to blisters and erosions, and woolly hair that is unusually curly and coarse.
The test, priced at 4400 AED, involves the collection of a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic mutations in the DSP gene. Early diagnosis through this genetic test can be crucial for the management of the condition, enabling targeted treatment strategies and providing valuable information for family planning. DNA Labs UAE utilizes state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of the test results, offering a vital resource for individuals and families affected by this syndrome.
The SLC24A4 gene plays a crucial role in determining the pigmentation of skin, hair, and eyes, influencing the diversity of human appearance. The Skin Hair Eye Pigmentation Type 6 Genetic Test, specifically targeting the SLC24A4 gene, is designed to uncover variations that may predict pigmentation traits. This sophisticated genetic test, offered at DNA Labs UAE, provides individuals with insights into their genetic makeup regarding pigmentation, potentially explaining certain characteristics or familial traits.
Priced at 4400 AED, the test is a valuable tool for those seeking to understand more about their genetic predisposition to pigmentation types. Conducted in a state-of-the-art facility, DNA Labs UAE ensures accuracy and confidentiality, making it a reliable choice for genetic testing services. This test not only offers personal insights but can also be significant for research, medical, or cosmetic purposes, contributing to a broader understanding of human genetics and the intricate mechanisms behind pigmentation.
The DYM Gene Smith-McCort Dysplasia Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the DYM gene that are associated with Smith-McCort dysplasia. Smith-McCort dysplasia is a rare genetic disorder characterized by skeletal abnormalities, including short stature and specific bone malformations. Early and accurate diagnosis through this genetic test can significantly aid in the management and treatment planning for affected individuals.
This test involves analyzing the patient's DNA to look for specific mutations in the DYM gene that are known to cause the disorder. It is a critical step for families with a history of Smith-McCort dysplasia, providing them with essential information regarding the condition's presence and its potential transmission to future generations.
The cost of the DYM Gene Smith-McCort Dysplasia Genetic Test at DNA Labs UAE is 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify the genetic mutations associated with the condition. Upon completion of the test, patients receive a comprehensive report that details the findings and provides guidance on the next steps.
This genetic test is a valuable resource for affected families, offering them clarity on their genetic status and enabling informed decisions about their health and the health of their family members.
The FLNB Gene Spondylocarpotarsal Synostosis Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FLNB gene that are responsible for Spondylocarpotarsal Synostosis Syndrome (SCT). SCT is a rare genetic disorder characterized by the fusion of certain bones in the spine (vertebrae) and occasionally the fusion of carpal and tarsal bones in the hands and feet, leading to skeletal abnormalities and restricted mobility. This test plays a crucial role in the early diagnosis and management of the syndrome, enabling healthcare providers to offer appropriate treatments and interventions to improve the quality of life for affected individuals. The test is priced at 4400 AED, reflecting the specialized expertise and advanced technology employed in detecting the genetic variations associated with this condition. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into the genetic underpinnings of SCT, facilitating informed decisions about care and management.
The SLC39A13 gene is associated with a rare genetic condition known as Spondylocheirodysplasia, Ehlers-Danlos Syndrome-like (SCD-EDS). This condition is characterized by a combination of skeletal and connective tissue abnormalities, including but not limited to, short stature, hyperelastic skin, and distinctive facial features. The SLC39A13 gene plays a crucial role in the regulation of zinc transport in cells, which is essential for the normal development and maintenance of connective tissue.
To diagnose this condition, a specific genetic test can be performed, which involves analyzing the SLC39A13 gene for mutations that are known to cause Spondylocheirodysplasia, Ehlers-Danlos Syndrome-like. This test is crucial for confirming the diagnosis, understanding the inheritance pattern, and providing appropriate genetic counseling to affected families.
In the UAE, DNA Labs offers this genetic testing service. The test cost is 4400 AED. DNA Labs UAE is a reputable institution known for its advanced genetic testing capabilities, providing accurate and reliable results. Opting for this test at DNA Labs UAE ensures that individuals and families receive comprehensive support, from the initial consultation to the interpretation of results and guidance on the subsequent steps.
The DLL3 gene spondylocostal dysostosis autosomal recessive type 1 genetic test is a specific diagnostic tool designed to detect mutations in the DLL3 gene, which are responsible for spondylocostal dysostosis type 1 (SCDO1). SCDO1 is a rare genetic disorder characterized by abnormal development of the vertebrae and ribs, leading to a short trunk, scoliosis, and other skeletal anomalies. The condition follows an autosomal recessive inheritance pattern, meaning that two copies of the defective gene, one from each parent, are required for a child to be affected.
This genetic test is crucial for early diagnosis, which can significantly influence the management and treatment options for affected individuals. It involves analyzing the patient's DNA to identify mutations in the DLL3 gene, providing valuable information for families regarding recurrence risks and guiding decisions about future pregnancies.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. By opting for this test at DNA Labs UAE, patients and their families can expect comprehensive support, from initial consultation through to result interpretation and counseling on the implications of the findings.
The MESP2 gene plays a crucial role in the development of the vertebrae and ribs. Mutations in this gene can lead to a condition known as Spondylocostal Dysostosis, Autosomal Recessive Type 2 (SCDO2). This genetic disorder is characterized by abnormal development of the spine and ribs, leading to a shortened trunk, among other skeletal anomalies. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the MESP2 gene, aiding in the diagnosis of Spondylocostal Dysostosis, Autosomal Recessive Type 2. The test is a crucial tool for families with a history of the condition or for individuals showing symptoms, as it can provide definitive confirmation of the diagnosis. The cost of the test is 4400 AED, and it involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the lab for the presence of mutations in the MESP2 gene.
This genetic testing not only helps in confirming the diagnosis but also aids in understanding the risk of passing the condition to future generations, thereby facilitating informed family planning decisions. Additionally, it can guide healthcare providers in managing and treating the condition more effectively, tailored to the individual's genetic makeup.
The LFNG Gene Spondylocostal Dysostosis Autosomal Recessive Type 3 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the LFNG gene, which are associated with Spondylocostal Dysostosis, Autosomal Recessive Type 3 (SCDO3). This condition is characterized by abnormal development of the vertebrae and ribs, leading to a shortened trunk, scoliosis, and other skeletal abnormalities. The test is crucial for early diagnosis, allowing for appropriate management and genetic counseling for affected families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the LFNG gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic alterations associated with SCDO3.
By opting for this genetic test, individuals with a family history of Spondylocostal Dysostosis or related symptoms can gain valuable insights into their genetic makeup, enabling informed decisions about their health and future.
The ACP5 gene test for Spondyloenchondrodysplasia with Immune Dysregulation is a specialized genetic examination offered by DNA Labs UAE. This test focuses on identifying mutations in the ACP5 gene, which are associated with spondyloenchondrodysplasia, a rare skeletal dysplasia characterized by vertebral and metaphyseal abnormalities alongside immune system dysregulation. This condition can lead to various clinical manifestations, including short stature, spinal abnormalities, and increased susceptibility to autoimmune disorders.
DNA Labs UAE provides this comprehensive genetic test at a cost of 4400 AED. The test is designed to offer crucial insights for individuals presenting symptoms of this disorder, enabling targeted management and treatment strategies. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the ACP5 gene. The results can assist healthcare providers in confirming a diagnosis, understanding the disease's progression, and implementing appropriate therapeutic interventions. Given the complexity of spondyloenchondrodysplasia with immune dysregulation, this genetic test is a valuable tool for affected individuals and their families, offering hope for improved outcomes through personalized medicine.
The B3GALT6 gene plays a crucial role in the development and maintenance of connective tissue, a key component of the body's structural framework. Mutations in this gene can lead to a rare genetic disorder known as Spondyloepimetaphyseal Dysplasia with Joint Laxity, Type 1, with or without fractures (SEMDJL1). This condition is characterized by skeletal abnormalities, including short stature, joint laxity, and in some cases, frequent fractures.
To diagnose this condition, a genetic test targeting the B3GALT6 gene can be conducted. This test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 3200 AED. Through this test, individuals suspected of having SEMDJL1 can receive a definitive diagnosis, enabling them to pursue appropriate treatment and management strategies for the condition. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.
